Pharmaceutical Manufacturing of Sterile IV Solutions

The contract pertains to the manufacture and supply of 0.9% Sodium Chloride Injection, USP, in 100 mL containers, strictly adhering to FDA regulations, USP <797> for sterile compounding, and current good manufacturing practices to ensure safe sterile intravenous use. The product must meet all requisite quality and contamination control standards for clinical administration and is intended for procurement by the Department of Defense through its Medical Supply Chain Pharm FSA. The solicitation is issued as a subcontract under NAICS code 325412, with a response deadline of May 18, 2026, and the place of performance is specified as Fort Stewart, Georgia, with a zip code of 31314-5185. The contract was posted on May 10, 2026, and interested parties must submit proposals through the DIBBS portal prior to the deadline to be considered for award.